Evidence map›Paper›PMID 28258107›Full record

ArticleAmerican journal of physiology. Lung cellular and molecular physiology2017

Nonantibiotic macrolides restore airway macrophage phagocytic function with potential anti-inflammatory effects in chronic lung diseases.

Sandra Hodge, Hai B Tran, Rhys Hamon, Eugene Roscioli, Greg Hodge, Hubertus Jersmann, Miranda Ween, Paul N Reynolds, Arthur Yeung, Jennifer Treiberg and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in American journal of physiology. Lung cellular and molecular physiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 63 citations in OpenAlex.

  1. When clearance fails: the role of efferocytosis in COPD.European respiratory review : an official journal of the European Respiratory Society · 2026
    Review
  2. Review
  3. Efferocytosis in Homeostasis.Advances in experimental medicine and biology · 2025
    Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Efferocytosis in multisystem diseases (Review).Molecular medicine reports · 2022
    Review
  10. Article
  11. E-cigarettes and health risks: more to the flavor than just the name.American journal of physiology. Lung cellular and molecular physiology · 2021
    Article
  12. Review
  13. Leukocyte Function in COPD: Clinical Relevance and Potential for Drug Therapy.International journal of chronic obstructive pulmonary disease · 2021
    Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. The non-antibiotic macrolide EM900 attenuates HDM and poly(I:C)-induced airway inflammation with inhibition of macrophages in a mouse model.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2020
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Sandra HodgeLung Research Unit, Hanson Institute, and Department of Thoracic Medicine, Royal Adelaide Hospital, Adelaide, Australia; sandra.hodge@sa.gov.au.
Hai B TranLung Research Unit, Hanson Institute, and Department of Thoracic Medicine, Royal Adelaide Hospital, Adelaide, Australia.
Rhys HamonLung Research Unit, Hanson Institute, and Department of Thoracic Medicine, Royal Adelaide Hospital, Adelaide, Australia.
Eugene RoscioliLung Research Unit, Hanson Institute, and Department of Thoracic Medicine, Royal Adelaide Hospital, Adelaide, Australia.
Greg HodgeLung Research Unit, Hanson Institute, and Department of Thoracic Medicine, Royal Adelaide Hospital, Adelaide, Australia.
Hubertus JersmannLung Research Unit, Hanson Institute, and Department of Thoracic Medicine, Royal Adelaide Hospital, Adelaide, Australia.
Miranda WeenLung Research Unit, Hanson Institute, and Department of Thoracic Medicine, Royal Adelaide Hospital, Adelaide, Australia.
Paul N ReynoldsLung Research Unit, Hanson Institute, and Department of Thoracic Medicine, Royal Adelaide Hospital, Adelaide, Australia.
Arthur YeungGilead Sciences, Seattle, Washington.
Jennifer TreibergGilead Sciences, Seattle, Washington.
Sibylle WilbertGilead Sciences, Seattle, Washington.
University of Adelaide · AUGilead Sciences (United States) · USHanson Institute · AURoyal Adelaide Hospital · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We reported defective efferocytosis associated with cigarette smoking and/or airway inflammation in chronic lung diseases, including chronic obstructive pulmonary disease, severe asthma, and childhood bronchiectasis. We also showed defects in phagocytosis of nontypeable

Indexed as

AdultAnti-Bacterial AgentsAnti-Inflammatory AgentsApoptosisCell LineCell SurvivalChronic DiseaseErythromycinFlow CytometryFluorescent Antibody TechniqueHaemophilus influenzaeHumansInterleukin-1betaLungLung DiseasesMacrolides2'-desoxy-9-erythromycylamineAnti-Bacterial AgentsAnti-Inflammatory AgentsErythromycinInterleukin-1betaMacrolidesMAS1 protein, humanNLR Family, Pyrin Domain-Containing 3 ProteinNLRP3 protein, humanProto-Oncogene MasReceptors, Cell Surfaceazithromycinchronic lung diseasechronic obstructive pulmonary diseasenonantibiotic macrolidesnontypeable H. influenzae

Identifiers

PMID28258107
PMCPMC5451592
OpenAlexW2592896300

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.